- $91.77m
- -$51.58m
- CNY985.52m
- 91
- 99
- 35
- 88
Annual income statement for Ihuman, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 132 | 219 | 532 | 945 | 986 |
| Cost of Revenue | |||||
| Gross Profit | 66 | 134 | 365 | 661 | 691 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 154 | 497 | 576 | 999 | 874 |
| Operating Profit | -22.1 | -279 | -44.5 | -54.2 | 112 |
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -16 | -274 | -37 | -37.2 | 133 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -17.6 | -276 | -37.5 | -37.1 | 110 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -17.6 | -276 | -37.5 | -37.1 | 110 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -17.6 | -276 | -48.3 | -37.1 | 110 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.078 | -1.22 | -0.213 | -0.139 | 0.406 |